Table 3.
Urinary sucrose levels of rats grouped according to lesion status.
| Groupa | Lesion status | N | Urinary sucrose levels | |
|---|---|---|---|---|
| Mean (mg/sample) | SD | |||
| Control | No lesions | 35 | 16.35 | 6.72 |
| Lesions | 5 | 18.86 | 11.23 | |
| All | 40 | 16.66 | 7.28 | |
| NSAID | No lesions | 8 | 31.56 | 10.24 |
| Lesions | 32 | 21.57 | 9.21 | |
| All | 40 | 23.57 | 10.13 | |
| Probiotic | No lesions | 9 | 17.42 | 7.64 |
| Lesions | 30 | 17.45 | 8.41 | |
| All | 39 | 17.45 | 8.14 | |
aThe treatment groups were control, indomethacin-challenged group (NSAID), and a probiotic group supplemented daily with 1010 colony forming units of Bifidobacterium lactis 420 for seven days prior to indomethacin challenge.